用钱伯文教授经验方加减治疗53例原发性肝癌，结果1、3、5年的生存率分别为73.58％、38.66％和22.57％，并可提高生存质量。临床及实验研究显示，钱氏肝癌方以益气健脾、清热化湿为主的组方原则有其科学依据，提示脾虚“肝郁”是肝癌的重要病机，该方对原发性肝癌术后延长生存期有重要意义。 Using Professor Qian Bowen’s experience in addition and subtraction to treat 53 cases of primary liver cancer, the survival rates at 1, 3, and 5 years were 73.58%, 38.66%, and 22.57%, respectively, and the quality of life could be improved. Clinical and experimental studies have shown that Qian’s liver cancer has a scientific basis for the principles of Qi-invigorating spleen, heat-clearing and dehumidification, and suggests that the spleen deficiency “liver stagnation” is an important pathogenesis of liver cancer. This side affects primary liver cancer. Postoperative survival is important.